U.S. Electrical Stock News

NasdaqGS:FNKO
NasdaqGS:FNKOLeisure

Funko (FNKO) Posts Breakeven Q4 EPS Keeping Profitability Debate In Focus

Funko (FNKO) has wrapped up FY 2025 with Q4 revenue of US$273.1 million and a small net loss of US$0.2 million, translating to a basic EPS of roughly US$0.00 per share. Trailing 12 month figures show revenue of US$908.2 million and a net loss of US$67.4 million, or a basic EPS loss of US$1.24. The company has seen quarterly revenue range from US$190.7 million to US$273.1 million over the year, with EPS moving between a loss of US$0.74 and a profit of US$0.02. This keeps the focus on how...
NasdaqGS:ARTN.A
NasdaqGS:ARTN.AWater Utilities

Artesian Resources (ARTNA) Margin Strength Supports Bullish Narratives After Q3 FY 2025 Earnings

Artesian Resources (ARTNA) has wrapped up its latest quarter with Q3 FY 2025 revenue of US$30.5 million and basic EPS of US$0.68, alongside trailing 12 month revenue of US$111.8 million and EPS of US$2.19 that frame the broader earnings picture. Over recent quarters the company has seen revenue move from US$25.9 million and EPS of US$0.53 in Q1 FY 2025 to US$28.5 million and EPS of US$0.61 in Q2, before reaching the current Q3 levels. With trailing net profit margins at 20.2% and earnings up...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Does New Once-Yearly SMA Data And Phase 3 Plan Change The Bull Case For Biogen (BIIB)?

In early March 2026, Biogen reported additional Phase 1b data for its investigational once-yearly SMA therapy salanersen, showing sustained safety, slowing of neurodegeneration, and new WHO motor milestones in children previously treated with gene therapy, while also outlining a global Phase 3 program spanning infants to adults. The breadth of the upcoming STELLAR and SOLAR Phase 3 trials, alongside biomarker evidence such as durable neurofilament light chain reductions, underlines how...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Nektar Therapeutics (NKTR) Q3 Losses Narrow To US$35.5 Million Testing Bearish Narratives

Nektar Therapeutics (NKTR) kicked off FY 2025 with a third quarter that paired modest revenue with deep losses, reporting Q3 revenue of US$11.8 million, basic EPS of a US$1.87 loss and a net income loss of US$35.5 million. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 and US$24.1 million in Q3 2024 to US$10.5 million, US$11.2 million and US$11.8 million over the first three quarters of 2025. Basic EPS shifted from a US$3.76 loss and US$2.66 loss in Q2 and Q3 2024...
NasdaqGM:OFLX
NasdaqGM:OFLXMachinery

Omega Flex (OFLX) Margin Decline Challenges Quality Industrial Narrative

Omega Flex (OFLX) just wrapped up FY 2025 with fourth quarter revenue of US$25.2 million and EPS of US$0.34, alongside trailing twelve month revenue of US$98.3 million and EPS of US$1.47 that sit below the prior year’s trailing figures of US$101.7 million and US$1.78 respectively. Over recent periods, quarterly revenue has moved in a tight band between US$23.3 million and US$26.0 million while quarterly EPS has ranged from US$0.35 to US$0.46. This puts the spotlight squarely on how...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Is Azenta (AZTA) Now Offering Value After A 75% Five Year Share Price Slide

If you are wondering whether Azenta's current share price reflects its true worth, this article walks through what the numbers are actually saying about the stock. Azenta's recent share price has come under pressure, with returns of 11.9% decline over 7 days, 29.7% decline over 30 days, 35.8% decline year to date, 41.8% decline over 1 year and 45.8% decline over 3 years, extending to a 75.0% decline over 5 years from a last close of US$21.42. These moves have sharpened the focus on whether...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Net Margin Near 30% Tests Bullish Profit Expansion Narratives

Adobe (ADBE) opened fiscal Q1 2026 with revenue of about US$6.4 billion and basic EPS of US$4.61, setting the tone for another earnings update that keeps the focus firmly on the income statement. The company has seen quarterly revenue move from US$5.6 billion in Q4 2024 to US$6.4 billion in Q1 2026, while basic EPS has shifted from US$3.82 to US$4.61 over the same stretch, providing a clear view of how the top and bottom lines have tracked together as net profit margins remain an important...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Is It Too Late To Consider Leonardo DRS (DRS) After Its Strong Share Price Run?

If you are wondering whether Leonardo DRS is still priced sensibly after its recent run, this article will walk through what the current share price might be implying about value. The stock recently closed at US$45.30, with returns of 19.6% over the last 30 days, 30.2% year to date and 41.8% over the past year, following a very large 3 year gain of 266.7%. Over the last 7 days the share price showed a 2.7% decline. Recent coverage around Leonardo DRS has focused on its role within the...
NYSE:VSTS
NYSE:VSTSCommercial Services

Assessing Vestis (VSTS) Valuation After Recent Share Price Weakness

Vestis: context for the recent share move Vestis (VSTS) has been on many watchlists after recent trading left the stock around $7.59, with a month return of about a 12% decline and a year total return of roughly a 30% decline. See our latest analysis for Vestis. At the latest share price of $7.59, Vestis has seen a 12.46% 1 month share price decline, although the year to date share price return of 15.35% contrasts with a 29.79% 1 year total shareholder return decline. This suggests recent...
NYSE:GPGI
NYSE:GPGITech

GPGI (GPGI) Half Year Loss Narrows To US$4.6 Million Challenging Bearish Narratives

GPGI (GPGI) has just posted its FY 2025 first half results, with revenue of US$59.8 million and a basic EPS loss of US$0.05, alongside trailing 12 month revenue of US$59.8 million and a net loss of US$136.0 million. Over the past three reported halves, revenue has moved from US$212.6 million in 1H 2024 to US$208.0 million in 2H 2024 and now US$59.8 million in 1H 2025. Basic EPS has shifted from a profit of US$1.11 in 1H 2024 to losses of US$1.22 in 2H 2024 and US$0.05 in the latest period,...
NYSE:WT
NYSE:WTCapital Markets

Is WisdomTree (WT) Quietly Recasting Its Identity Around Rules-Based Risk Management?

In March 2026, WisdomTree, Inc. launched two Nasdaq-listed adaptive trend-following ETFs, the U.S. Adaptive Moving Average Fund (WAMA, 0.32% expense ratio) and the International Adaptive Moving Average Fund (WIMA, 0.42% expense ratio), which systematically shift between equities and U.S. Treasury bills based on 200-day moving-average signals. By pairing these adaptive ETFs with its new defined outcome Structured Income SMA built with Halo Investing, WisdomTree is broadening beyond...
NYSE:PD
NYSE:PDSoftware

PagerDuty (PD) Profitability Milestone Sparks Debate Over Earnings Quality And Bearish Forecasts

PagerDuty (PD) has just closed out FY 2026 with Q4 revenue of US$124.8 million and basic EPS of US$0.13, alongside trailing 12 month revenue of US$492.5 million and basic EPS of US$1.91 that reflect its recent move into profitability. The company has seen quarterly revenue move from US$118.9 million in FY 2025 Q3 to US$124.8 million in FY 2026 Q4, while basic EPS has swung from a loss of US$0.12 in FY 2025 Q4 to a profit of US$0.13 in the latest quarter. This sets up a story where improving...
NYSE:TRGP
NYSE:TRGPOil and Gas

The Bull Case For Targa Resources (TRGP) Could Change Following Record 2025 EBITDA And Higher 2026 Guidance

Targa Resources recently reported record 2025 adjusted EBITDA of about US$5.00 billion, a 20% year-over-year increase, supported by higher processing, transportation, and fractionation volumes tied to Permian Basin activity and new midstream infrastructure projects and acquisitions. Management’s projection for 2026 EBITDA of US$5.40 billion to US$5.60 billion, alongside US$642.00 million of share repurchases and analyst upgrades, highlights how expanding assets and capital returns are...
NasdaqCM:SHIM
NasdaqCM:SHIMConstruction

Shimmick (SHIM) Q4 Loss Narrowing Tests Bullish Turnaround Narrative

Shimmick (SHIM) has wrapped up FY 2025 with Q4 revenue of US$100.4 million and a basic EPS loss of US$0.09, alongside trailing 12 month revenue of US$492.8 million and a total net loss of US$25.6 million. The company has seen quarterly revenue move from US$122.1 million in Q1 2025 to US$141.9 million in Q3 2025, before landing at US$100.4 million in Q4. Over the same stretch, quarterly basic EPS stayed in loss territory between US$0.28 and US$0.09 per share. Taken together, the latest print...
NYSE:OFRM
NYSE:OFRMFood

Once Upon A Farm PBC (OFRM) Q3 Loss Deepens And Tests Bullish Profitability Narratives

Once Upon A Farm PBC (OFRM) has just posted its FY 2025 third quarter results, with revenue at US$66.0 million and a basic EPS loss of US$1.69, set against trailing twelve month revenue of US$225.9 million and a loss of US$7.84 per share. The company has seen quarterly revenue move from US$41.8 million in Q3 2024 to US$66.0 million in Q3 2025, while quarterly EPS moved from a loss of US$1.15 to a loss of US$1.69. Investors will be weighing that expanding top line against still weak margins...
OTCPK:FNRN
OTCPK:FNRNBanks

First Northern Community Bancorp (OTCPK:FNRN) Margin Strength Challenges Cautious Narratives

First Northern Community Bancorp (FNRN) has wrapped up FY 2025 with fourth quarter revenue of US$20.0 million and EPS of US$0.35, alongside net income of US$6.0 million. Over recent quarters the bank has seen revenue move from US$18.5 million and EPS of US$0.37 in Q3 2025 to US$20.0 million and EPS of US$0.35 in Q4, with earlier 2025 quarters at US$18.5 million and EPS of US$0.33 in Q2, and US$16.5 million and EPS of US$0.22 in Q1. With a trailing net profit margin of 29.2%, these results...
NasdaqGS:LMNR
NasdaqGS:LMNRFood

Limoneira (LMNR) Loss Deepens In Q1 2026 Challenging Profitability Recovery Narratives

Limoneira (LMNR) has kicked off Q1 2026 with revenue of US$18.2 million and a basic EPS loss of US$0.53, alongside a trailing twelve month EPS loss of US$1.28 on revenue of US$143.6 million, setting a cautious tone around profitability. The company has seen quarterly revenue move from US$34.3 million in Q1 2025 to US$18.2 million in Q1 2026, while basic EPS shifted from a loss of US$0.18 to a loss of US$0.53, putting the focus squarely on how efficiently each dollar of sales is translating...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Should MACOM’s New PCIe 7.0 and Optical Lineup at OFC 2026 Reshape MTSI’s AI Narrative?

In March 2026, MACOM Technology Solutions showcased an extensive range of advanced photonics, optoelectronic and copper interconnect solutions at OFC 2026, highlighting products aimed at AI data centers, cloud infrastructure and high-speed networking, alongside announcing industry-first PCIe 7.0–optimized linear equalizer and cross-point switch devices. This combination of cutting-edge optical transmit, PCIe 6.0/7.0 and coherent lite solutions underlines MACOM’s ambition to be a key enabler...
OTCPK:HKHC
OTCPK:HKHCPersonal Products

Horizon Kinetics Holding (OTCPK:HKHC) 400% Earnings Growth Reinforces Bullish Narratives

Horizon Kinetics Holding (HKHC) just posted fresh FY 2025 numbers, with Q3 revenue of US$17.9 million, basic EPS of US$0.39 and net income from continuing operations of US$7.3 million setting the tone for how the year is shaping up. Looking back over recent quarters, revenue has moved from US$13.1 million in Q3 2024 to US$14.7 million in Q4 2024, then to US$19.8 million in Q1 2025 and US$17.9 million in Q3 2025. Over the same period, basic EPS shifted from a loss of US$2.06 in Q3 2024 to...
NasdaqCM:JYNT
NasdaqCM:JYNTHealthcare

Joint (JYNT) Returns To Quarterly Profit Challenging Persistent Loss Narrative

Joint (JYNT) has just posted its FY 2025 third quarter numbers, with revenue of US$13.4 million and basic EPS of US$0.02, alongside trailing twelve month revenue of US$54.2 million and a trailing EPS loss of US$0.01. Over recent quarters the company has seen quarterly revenue move from US$12.6 million in Q3 2024 to US$14.4 million in Q4 2024, then to US$13.1 million, US$13.3 million and now US$13.4 million. Basic EPS has ranged from a loss of US$0.11 in Q2 2024 to a profit of US$0.07 in Q4...
NYSE:KMPR
NYSE:KMPRInsurance

Is Kemper (KMPR) Rebalancing Geographic Risk or Sacrificing Scale With Its Post‑California Shift?

On March 3, 2026, Kemper Corporation’s interim CEO outlined at a Raymond James conference how higher minimum auto liability limits in California have pressured profitability and prompted a recalibration of its auto insurance business. An important takeaway was Kemper’s plan to reduce earnings volatility by shifting growth emphasis toward markets such as Florida and Texas, aiming to balance its geographic exposure. Next, we’ll examine how Kemper’s push to grow beyond California could...
NasdaqCM:PRQR
NasdaqCM:PRQRBiotechs

ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns

ProQR Therapeutics (NasdaqCM:PRQR) has wrapped up FY 2025 with fourth quarter revenue of €4.7 million and a basic EPS loss of €0.08, alongside a net income loss of €8.9 million. These figures put hard numbers around where the business stands today. Over recent periods the company has seen quarterly revenue range from €2.9 million to €4.7 million, while quarterly basic EPS has moved between a loss of €0.12 and a loss of €0.08. As a result, the story for investors remains centered on how...
NasdaqCM:SKIN
NasdaqCM:SKINPersonal Products

Beauty Health (SKIN) Losses Narrow In Q4 Yet Forecast Earnings Declines Challenge Bullish Narratives

Beauty Health (SKIN) closed FY 2025 with fourth quarter revenue of US$82.4 million and a basic EPS loss of US$0.06, alongside trailing twelve month revenue of US$300.8 million and a basic EPS loss of US$0.08. The company has seen quarterly revenue move between US$69.6 million and US$83.5 million over the recent periods. Basic EPS has ranged from a profit of US$0.16 per share in Q2 2025 to losses of around US$0.08 to US$0.15 per share in other quarters, setting up a mixed picture for margins...
NasdaqCM:VFF
NasdaqCM:VFFFood

Village Farms International (VFF) Profitability Turnaround Tests Bullish Margin Narratives

Village Farms International (NasdaqCM:VFF) has just wrapped up FY 2025 with fourth quarter revenue of US$49.6 million and basic EPS of US$0.02, capping a year in which trailing twelve month EPS reached US$0.19 on revenue of US$215.9 million. Over the past few quarters, the company has seen quarterly revenue move from US$39.7 million in Q1 2025 to US$66.7 million in Q3 2025 before settling at US$49.6 million in Q4, while quarterly EPS shifted from a loss of US$0.02 in Q1 to US$0.09 in both Q2...